Trade ARQT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Arcutis Biotherapeutics, Inc. (ARQT) is trading at US$27.78, up 7.01% today as of Sep 22, 16:00 EDT. The company has a market capitalisation of US$3.15B. Over the past 52 weeks, ARQT has traded between US$16.57 and US$31.77. On Syfe you can trade ARQT with $0 commission and add it to your watchlist.
| Previous close | US$25.96 |
|---|---|
| Market cap | US$3.15B |
| P/E ratio | 25.28 |
| 52-week range | US$16.57 – US$31.77 |
| Volume | 2.86M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.
Year: 2020
Arcutis Biotherapeutics' Zoryve Gets Health Canada Approval for Children With Atopic Dermatitis
Aug 20, 5:55 PM · MT Newswires
-- Earnings Flash (ARQT) Arcutis Biotherapeutics, Inc. Reports Q2 Revenue $129.9M, vs. FactSet Est of $118.9M
Aug 5, 8:01 PM · MT Newswires
Arcutis Biotherapeutics Says FDA Accepted ZORYVE Expansion Filing for Infants With Eczema
Jul 8, 12:59 PM · MT Newswires
Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday
Jun 30, 1:23 PM · MT Newswires
Arcutis Biotherapeutics, Inc. (ARQT) stock is trading at US$27.78, +7.01% from the previous close of US$25.96.
The market cap for Arcutis Biotherapeutics, Inc. (ARQT) stock is approximately US$3.15B.
The price-to-earnings ratio for Arcutis Biotherapeutics, Inc. (ARQT) is 25.28, based on the latest reported earnings.
The 52-week high for Arcutis Biotherapeutics, Inc. (ARQT) stock is US$31.77.
The 52-week low for Arcutis Biotherapeutics, Inc. (ARQT) stock is US$16.57.
Arcutis Biotherapeutics, Inc. (ARQT) does not currently pay a dividend.
Stay on top of ARQT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
